Tumor necrosis factor family member eiger
| GO Term | Evidence Code | Reference |
|---|---|---|
| response to tumor cell | ||
| apoptotic process | ||
| apoptotic process | ||
| immune response | ||
| immune response |
| GO Term | Evidence Code | Reference |
|---|---|---|
| obsolete extracellular space |
|
|
| plasma membrane | ||
| plasma membrane | ||
| cytoplasmic vesicle | ||
| cytoplasmic vesicle |
| GO Term | Evidence Code | Reference |
|---|---|---|
| signaling receptor binding | ||
| cytokine activity | ||
| tumor necrosis factor receptor binding | ||
| tumor necrosis factor receptor superfamily binding | ||
| tumor necrosis factor receptor superfamily binding |
| Pathway Name | Organism |
|---|---|
| HuR (ELAVL1) binds and stabilizes mRNA | Drosophila melanogaster |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:305 | carcinoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026